Induction of pulmonary fibrosis by cerium oxide nanoparticles

Toxicology and Applied Pharmacology

Volumn 262, Issue 3, 2012, Pages 255-264

  Ma, Jane Y ^a   Mercer, Robert R ^a   Barger, Mark ^a   Schwegler Berry, Diane ^a   Scabilloni, James ^a   Ma, Joseph K ^b   Castranova, Vincent ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cerium oxide; Metalloproteinases; Nanoparticle; Phospholipidosis; Pulmonary fibrosis

Indexed keywords

CERIUM OXIDE; COLLAGEN FIBER; GELATINASE A; GELATINASE B; HYDROXYPROLINE; NANOPARTICLE; OSTEOPONTIN; PHOSPHOLIPID; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CERIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYPROLINE; LUNG; MACROPHAGES, ALVEOLAR; MALE; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OSTEOPONTIN; PULMONARY FIBROSIS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 84863823390     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.05.005     Document Type: Article

References (48)

1. Antonini J.M., Hemenway D.R., Davis G.S. Quantitative image analysis of lung connective tissue in murine silicosis. Exp. Lung Res. 2000, 26:71-88.
2. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 1959, 234:466-468.
3. Berman J.S., Serlin D., Li X., Whitley G., Hayes J., Rishikof D.C., Ricupero D.A., Liaw L., Goetschkes M., O'Regan A.W. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 2868i:L1311-L1318.
4. Bonniaud P., Kolb M., Galt T., Robertson J., Robbins C., Stampfli M., Lavery C., Margetts P.J., Roberts A.B., Gauldie J. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J. Immunol. 2004, 173:2099-2108.
5. Corbel M., Boichot E., Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz. J. Med. Biol. Res. 2000, 33:749-754.
6. Denhardt D.T., Guo X. Ostepontin: a protein with diverse functions. FASEB J. 1993, 7:1475-1482.
7. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 2001, 29:117-129.
8. Duncan D.B. Multiple range and multiple F tests. Biometrics 1955, 11:1-42.
9. EPA, U.S. Toxicological Review of Cerium Oxide and Cerium Compounds 2009, EPA/635/R-08/002F. http://www.epa.gov/iris/toxreviews/1018tr.pdf.
10. Gharaee-Kermani M., Hu B., Phan S.H., Gyetko M.R. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 2009, 16:1400-1417.
11. Gueders M.M., Foidart J.M., Noel A., Cataldo D.D. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur. J. Pharmacol. 2006, 533:133-144.
12. Hagimoto N., Kuwano K., Inoshima I., Yoshimi M., Nakamura N., Fujita M., Maeyama T., Hara N. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol. 2002, 168:6470-6478.
13. Health Effects Institute (HEI) Evaluation of human health risk from cerium added to diesel fuel. HEI Communication 2001, 9. Integrated Laboratory Systems, Boston, MA, USA.
14. Junqueira L.C.U., Bignolas G., Brentani R.R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 1979, 11:447-455.
15. Kivirikko K.I., Laitinen O., Prockop D.J. Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem. 1967, 19:249-255.
16. Lemjabbar H., Gosset P., Lechapt-Zalcman E., Franco-Montoya M.L., Wallaert B., Harf A., Lafuma C. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. Am. J. Respir. Cell. Mol. Biol. 1999, 20(5):903-913.
17. Liaw L., Almeida M., Hart C.E., Ross R., Schwartz S.M., Giachelli C.M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 1994, 74:214-224.
18. Ma J.Y., Barger M.W., Hubbs A.F., Castranova V., Weber S.L., Ma J.K. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis. J. Toxicol. Environ. Health 1999, 57:247-266.
19. Ma J.Y., Zhao H., Mercer R.R., Barger M., Rao M., Meighan T., Schwegler-Berry D., Castranova V., Ma J.K. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 2011, 5:312-325. (Oct 6).
20. Malkusch W., Rehn B., Bruch J. Advantages of sirius red staining for quantitative morphometric collagen measurements in lungs. Exp. Lung Res. 1995, 21:61-77.
21. McDonald J.W., Ghio A.J., Sheehan C.E., Bernhardt P.F., Roggli V.L. Rare earth (cerium oxide) pneumoconiosis: analytical scanning electron microscopy and literature review. Mod. Pathol. 1995, 8:859-865.
22. Munder M., Eichmann K., Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998, 160:5347-5354.
23. Nalabotu S.K., Kolli M.B., Triest W.E., Ma J.Y., Manne N.D., Katta A., Addagarla H.S., Rice K.M., Blough E.R. Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats. Int. J. Nanomedicine 2011, 6:2327-2335.
24. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V.L., Agresti C., Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 1998, 273:31262-31272.
25. Nau G.J., Guilfoile P., Chupp G.L., Berman J.S., Kim S.J., Kornfeld H., Young R.A. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6414-6419.
26. Oyarzun M.J., Clements J.A. Control of lung surfactant by ventilation, adrenergic mediators, and prostaglandins in the rabbit. Am. Rev. Respir. Dis. 1978, 117:879-891.
27. Pairon J.C., Roos F., Iwatsubo Y., Janson X., Billon-Galland M.A., Bignon J., Brochard P. Lung retention of cerium in humans. Occup. Environ. Med. 1994, 51:195-199.
28. Park E.J., Cho W.S., Jeong J., Yi J.H., Choi K., Kim Y., Park K. Induction of inflammatory responses in mice treated with cerium oxide nanoparticles by intratracheal instillation. J. Health Sci. 2010, 56:387-396.
29. Perez-Ramos J., de Lourdes Segura-Valdez M., Vanda B., Selman M., Pardo A. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am. J. Respir. Crit. Care Med. 1999, 160:1274-1282.
30. Porru S., Placidi D., Quarta C., Sabbioni E., Pietra R., Fortaner S. The potencial role of rare earths in the pathogenesis of interstitial lung disease: a case report of movie projectionist as investigated by neutron activation analysis. J. Trace Elem. Med. Biol. 2001, 14:232-236.
31. Porter D.W., Ramsey D., Hubbs A.F., Battelli L., Ma J., Barger M., Landsittel D., Robinson V.A., McLaurin J., Khan A., Jones W., Teass A., Castranova V. Time course of pulmonary response of rats to inhalation of crystalline silica: histological results and biochemical indices of damage, lipidosis, and fibrosis. J. Environ. Pathol. Toxicol. Oncol. 2001, 20(Suppl. 1):1-14.
32. Pozzi E., Salmona M., Masturzo P., Genghini M., Sceisi M., Spialtini L., Luisetti M. Role of alveolar phospholipids in bleomycin-induced pulmonary fibrosis in the rat. Respiration 1987, 51(Suppl. 1):23-32.
33. Prospect Toxicological review of nano cerium oxide. Support of Prospect: Ecotoxicology Test Protocols for Representative Nanomaterials in Support of the OECD Sponsorship Programme 2009, http://www.nanotechia-prospect.org/managed_assets/files/prospect_nano-ceo2_literature_review.pdf.
34. Sabbioni E., Pietra R., Gaglione P., Vocaturo G., Colombo F., Zanoni M., Rodi F. Long-term occupational risk of rare-earth pneumoconiosis. A case report as investigated by neutron activation analysis. Sci. Total Environ. 1982, 26:19-32.
35. Scabilloni J.F., Wang L., Antonini J.M., Roberts J.R., Castranova V., Mercer R.R. Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L7097-L7717.
36. Scotton C.J., Chambers R.C. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 2007, 132(4):1311-1321.
37. Selman M., Ruiz V., Cabrera S., Segura L., Ramirez R., Barrios R., Pardo A. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L562-L574.
38. Srinivas A., Rao P.J., Selvam G., Murthy P.B., Reddy P.N. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol. Lett. 2011, 205:105-115.
39. Takahashi F., Takahashi K., Okazaki T., Maeda K., Ienaga H., Maeda M., Kon S., Uede T., Fukuchi Y. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2001, 24:264-271.
40. Toya T., Takata A., Otaki N., Takaya M., Serita F., Yoshida K., Kohyama N. Pulmonary toxicity induced by intratracheal instillation of coarse and fine particles of cerium dioxide in male rats. Ind. Health 2010, 48:3-11.
41. Underwood E.E. Quantitative Stereology 1970, Addison-Wesley, Reading, MA.
42. Vocaturo G., Colombo F., Zanoni M., Rodi F., Sabbioni E., Pietra R. Human exposure to heavy metals. Rare earth pneumoconiosis in occupational workers. Chest 1983, 83:780-783.
43. Waring P.M., Watling R.J. Rare earth deposits in a deceased movie projectionist. A new case of rare earth pneumoconiosis?. Med. J. Aust. 1990, 153:726-730.
44. Willis B.C., Borok Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293:L525-L534.
45. Yang H.M., Barger M.W., Castranova V., Ma J.K., Yang J.J., Ma J.Y. Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: evidence of DEP suppression of macrophage activity. J. Toxicol. Environ. Health 1999, 58:261-278.
46. Yokel R.A., Florence R.L., Unrine J.M., Tseng M.T., Graham U.M., Wu P., Grulke E.A., Sultana R., Hardas S.S., Butterfield D.A. Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 2009, 3(3):234-248.
47. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14:163-176.
48. Zohar R., Zhu B., Liu P., Sodek J., McCulloch C.A. Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am. J. Physiol. Heart Circ. Physiol. 2004, 287:H1730-H1739.